Aktuellt
SENASTE
Redeye welcomes today's news that Acarix has received an important "breakthrough" order from the US Veterans Health Administration (VA). The initial value of the order is cSEK1m, but it is expected to generate additional sales as the volume of patches accumulates over time. Additionally, we emphasize that this marks the first communicated order from the VA, which boosts confidence for potential future orders and presents a substantial commercial opportunity for Acarix. We reiterate our SEK0.7 base case.
LÄS MER
